Cita APA

ZHAO, L., YU, T., LI, C., LAI, Y., & CHEN, Q. (2014). Somatostatin administration prior to ERCP is effective in reducing the risk of post-ERCP pancreatitis in high-risk patients. D.A. Spandidos.

Chicago Style Citation

ZHAO, LI-NA, TAO YU, CHU-QIANG LI, YU LAI, i QI-KUI CHEN. Somatostatin Administration Prior to ERCP Is Effective in Reducing the Risk of Post-ERCP Pancreatitis in High-risk Patients. D.A. Spandidos, 2014.

Cita MLA

ZHAO, LI-NA, et al. Somatostatin Administration Prior to ERCP Is Effective in Reducing the Risk of Post-ERCP Pancreatitis in High-risk Patients. D.A. Spandidos, 2014.